Athersys Return on Assets:
-86.57% for Dec. 31, 2012Athersys Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -86.57% |
| Sept. 30, 2012 | -103.1% |
| June 30, 2012 | -81.91% |
| March 31, 2012 | -68.58% |
| Dec. 31, 2011 | -66.16% |
| Sept. 30, 2011 | -52.30% |
| June 30, 2011 | -56.77% |
| March 31, 2011 | -55.43% |
| Dec. 31, 2010 | -48.97% |
| Sept. 30, 2010 | -59.05% |
| June 30, 2010 | -55.40% |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
ATHX Return on Assets Benchmarks
| Companies | |
|---|---|
| Osiris Therapeutics | -28.29% |
| Cleveland BioLabs | -66.57% |
| Celgene Corporation | 12.96% |
ATHX Return on Assets Rankings
| Overall |
41st percentile 4715 of 8002 |
| Sector |
23rd percentile 499 of 650 in Healthcare |
| Industry |
32nd percentile 160 of 237 in Biotechnology |
ATHX Return on Assets Range, Past 5 Years
| Minimum | -103.1% | Sep 2012 |
| Maximum | -34.37% | Jun 2008 |
| Average | -57.53% |
